Thu.May 13, 2021

article thumbnail

Merck, with new breast cancer data, aims to rebound from FDA rejection

Bio Pharma Dive

Study results could address concerns raised by FDA advisers who recently voted against approval of Keytruda in patients with early-stage breast cancer.

300
300
article thumbnail

Marketing to physicians

World of DTC Marketing

QUICK READ: Reaching physicians with key brand messages isn’t hard, but the online landscape has become crowded with many players. By far, Medscape is still number one in physician reach , and medical journal advertising has been proven to result in more branded Rx’s. Deloitte showed there is a significant trust gap between pharmaceutical companies and people working in healthcare.

Marketing 173
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Heron, on third attempt, secures FDA approval for non-opioid painkiller

Bio Pharma Dive

The San Diego-based biotech's drug, which will now be sold as Zynrelef, had perviously been rejected by the agency in 2019 and 2020.

article thumbnail

Strategies for Your Content Marketing to Have Greater Impact

World of DTC Marketing

It’s 2021. Trends are a whole lot different from what they were a decade ago. This doesn’t just relate to fashion or hobby choices, either. It’s also highly relevant in the marketing world. One of the most essential methods to generate organic traffic is content marketing when it comes to marketing. With the right content marketing strategy in place, a website has the ability to do that all-important climb to the first page of Google.

Marketing 164
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Third Rock launches biotech targeting 'notoriously difficult' DNA regulators

Bio Pharma Dive

With $82 million in hand, Flare Therapeutics is looking to create precision cancer drugs by going after a type of protein called transcription factors.

article thumbnail

QED Advocates New British Standard for Soil Sampling

Pharma Mirror

Industry specialists working on contaminated land are being urged to use the new British Standard BS 10176 for soil sampling. BS 10176 was introduced in August 2020 but tests using old methods, which do not conform to the new standard, are still being accepted by regulators and assessors, which has led to concerns that its use is still only sporadic.

More Trending

article thumbnail

Pharma TV Ad Spending Trends: Companies in the Top Ten this Week

XTalks

Given that people have spent most of the past year being locked down at home due to the COVID-19 pandemic, it comes as no surprise that much of that time has been spent binging content on TV and through digital streaming services. In light of this, pharma wasted no time throwing some added cash towards TV ads. Taking advantage of the opportunity, the top ten pharma brands spent 17 percent more on TV ads in April 2020 compared to just a month prior, raising their monthly ad expenditures from $156

Insulin 104
article thumbnail

Finding Freedom through Entrepreneurship: Startup Founder Shares Story

BioSpace

Have you ever thought seriously about entrepreneurship? While large organizations appear to dominate the life sciences industry, startups and small businesses have started to compete in the marketplace.

article thumbnail

To prevent next pandemic, scientists say we must regulate air like food and water

Scienmag

Credit: Martin Visser, Unsplash Humans in the 21st century spend most of their time indoors, but the air we breathe inside buildings is not regulated to the same degree as the food we eat and the water we drink. A group of 39 researchers from 14 countries, including two from the University of Colorado Boulder, […].

article thumbnail

Monoclonal Antibody Proves Worth in Asthma Study

BioSpace

Pivotal data from Amgen’s and AstraZeneca’s NAVIGATOR Phase III trial show tezepelumab, a potential first-in-class human monoclonal antibody, reduced asthma aggravations and exacerbations requiring hospitalizations better than placebo in patients with severe asthma.

Antibody 107
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

First UK patient joins Pfizer’s phase 3 DMD gene therapy trial

pharmaphorum

The first UK patient has enrolled on Pfizer’s phase 3 trial for its Duchenne muscular dystrophy (DMD) gene therapy. Pfizer’s CIFFREO study began in the US in January this year and has now begun enrolling eligible patients in the UK. The first patient was recruited in The Newcastle upon Tyne Hospitals NHS Foundation Trust, one of three UK sites for the clinical trial and part of 55 globally, across 15 countries.

article thumbnail

Heron Wins Approval for Non-Opioid Drug, Allay Therapeutics Launches in Pain Management Space

BioSpace

Shares of Heron Therapeutics climbs after it announced the U.S. FDA approved its non-opioid drug for extended pain relief following some surgeries.

article thumbnail

4 ways to embed data-driven best practice in pharma HCP communications

pharmaphorum

Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. Over the 12 months to December 2020 the number of global Veeva CRM Engage Meetings increased sixfold, while those held in Europe saw an eight-fold increase – with 200,000 remote meetings conducted in Europe in November alone.

article thumbnail

Humanigen On the Cusp of Filing for Lenzilumab EUA in Hospitalized COVID-19 Patients

BioSpace

Humanigen reported it had held a meeting with the FDA to discuss plans for filing an EUA for its lenzilumab for hospitalized, hypoxic COVID-19 patients by the end of May.

73
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Abbott’s AI-powered coronary imaging platform deployed in the UK

Pharma Times

Heart attack patients offered treatment with new technology at the Royal Free Hospital in London

91
article thumbnail

The first frost is the deepest

Scienmag

Credit: John Innes Centre The first frost of autumn may be grim for gardeners but the latest evidence reveals it is a profound event in the life of plants. The discovery may affect how we grow crops in a fluctuating climate and help us better understand molecular mechanisms in animals and humans. Much of our […].

article thumbnail

Merck's Blockbuster Keytruda Tries Again with New Data for TNBC Approval

BioSpace

Merck announced positive results from the late-stage KEYNOTE-522 study that should support its previous attempt that was stymied by a regulatory advisory committee in February and rejected by the U.S. FDA in March.

75
article thumbnail

PharmaTimes are proud to confirm the launch of the 2021 Sales Awards

Pharma Times

The 2021 Sales Awards have opened their doors for entry, continuing its legacy of uncovering and rewarding exceptional talent within the pharma sales sector.

Sales 68
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Ozone in air pollution is linked to fibroid development in Black women

Scienmag

Credit: Dr Amelia Wesselink Higher levels of ozone from air pollution are linked to an increased risk of developing fibroids among Black American women according to a large study published today (Friday) in Human Reproduction [1], one of the world’s leading reproductive medicine journals. Fibroids are non-cancerous growths that develop in and around the womb. […].

article thumbnail

Novo Nordisk’s weight loss drug semaglutide found to improve wellbeing

Pharma Times

New results from a Phase IIIa study demonstrate benefits of drug for people with obesity 'beyond weight loss'

Drugs 77
article thumbnail

AZ/Daiichi unveil data from TNBC hopeful datopotamab deruxtecan

pharmaphorum

AstraZeneca and Daiichi Sankyo have revealed new data from datopotamab deruxtecan in triple negative breast cancer (TNBC) – and although it’s from a small patient group results look impressive. To recap, AZ shelled out $1bn for rights to datopotamab last year, an antibody-drug conjugate (ADC) consisting of an antibody that targets tumours and a lethal payload that kills cancer cells.

article thumbnail

Pfizer enrols first UK participant into global DMD gene therapy study

Pharma Times

The CIFFREO study is expected to enrol 99 ambulatory male patients aged four to seven years old

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Orangutan finding highlights need to protect habitat

Scienmag

Iconic great apes in Borneo lost muscle during fruit shortages Credit: Kristana Parinters Makur/Tuanan Orangutan Research Project Wild orangutans are known for their ability to survive food shortages, but scientists have made a surprising finding that highlights the need to protect the habitat of these critically endangered primates, which face rapid habitat destruction and threats […].

article thumbnail

Cancer drug developer aims to transform treatment

Outsourcing Pharma

A leader from clinical-stage pharma firm NuCana shares promising results for its ProTides therapies and hopes the drugs can elevate outcomes for patients.

Drugs 61
article thumbnail

Count your blessings: Short gratitude intervention can increase academic motivation

Scienmag

Keeping a daily gratitude journal for as little as two weeks can help keep students motivated for months Credit: Ritsumeikan University and the National Institute of Information and Communications Technology (NICT), Japan It is difficult for us to succeed in whatever we set out to do if we lack motivation. We usually need it as […].

56
article thumbnail

Biogen's Gene Therapy Strikes Out in Phase II/III Retinitis Pigmentosa Trial

BioSpace

Biogen reported that its gene therapy, cotoretigene toliparvovec, failed to hit the primary endpoint of the Phase II/III XIRIUS trial for X-linked retinitis pigmentosa (XLRP).

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Force-sensing PIEZO proteins are at work in plants, too

Scienmag

Proteins that enable the sense of touch in humans have an evolutionary cousin that helps plants grow their root systems Credit: Seyed Ali Reza Mousavi, PhD / Scripps Research LA JOLLA, CA–A family of proteins that sense mechanical force–and enable our sense of touch and many other important bodily functions–also are essential for proper root […].

Protein 54
article thumbnail

Interline Will Focus $92 Million Investment to Advance Precision Medicine Platform

BioSpace

Foresite Labs-incubated company Interline Therapeutics announced Thursday that it had raised $92 million in a financing round co-led by Foresite Capital and ARCH Venture Partners.

article thumbnail

Above the noise

Scienmag

Researchers at Osaka University use deep learning to reduce noise in the electrical current data collected from nanopores, which may lead to higher precision measurements when working with very tiny experiments or medical diagnostics Credit: Osaka University Osaka, Japan – Scientists from the Institute of Scientific and Industrial Research at Osaka University used machine learning […].

article thumbnail

Drug developer uses RWE to research psychedelic therapies

Outsourcing Pharma

The UK-based development and research firm hopes to accelerate patient access to psychedelic therapies for treatment of various mental health conditions.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.